CAZZATO, MASSIMILIANO
 Distribuzione geografica
Continente #
EU - Europa 262
NA - Nord America 235
AS - Asia 103
AF - Africa 33
SA - Sud America 4
OC - Oceania 1
Totale 638
Nazione #
US - Stati Uniti d'America 232
IT - Italia 102
SE - Svezia 68
SG - Singapore 36
IN - India 24
CN - Cina 21
DE - Germania 21
GB - Regno Unito 19
CI - Costa d'Avorio 18
BG - Bulgaria 17
SN - Senegal 8
FI - Finlandia 7
FR - Francia 7
NG - Nigeria 7
HK - Hong Kong 6
ID - Indonesia 5
PT - Portogallo 5
TR - Turchia 5
BR - Brasile 4
CZ - Repubblica Ceca 3
JP - Giappone 3
PL - Polonia 3
CA - Canada 2
CH - Svizzera 2
ES - Italia 2
VN - Vietnam 2
AU - Australia 1
EE - Estonia 1
IE - Irlanda 1
LV - Lettonia 1
MX - Messico 1
NL - Olanda 1
SI - Slovenia 1
TH - Thailandia 1
UA - Ucraina 1
Totale 638
Città #
Chandler 27
Santa Clara 26
Ashburn 25
Serra 23
Florence 22
Singapore 22
Abidjan 18
Sofia 17
London 15
Boardman 14
New York 13
Fairfield 11
Redwood City 11
Dakar 8
Princeton 8
Helsinki 7
Lagos 7
Lawrence 7
Marseille 7
Milan 7
Pisa 7
Dallas 6
Hong Kong 6
Hyderabad 6
Medford 6
Rome 6
Istanbul 5
Jakarta 5
Torres Vedras 5
Wilmington 5
Duncan 4
Kent 4
Munich 4
Quanzhou 4
Scarlino 4
Washington 4
Bremen 3
Cesano Boscone 3
Curitiba 3
Esslingen am Neckar 3
Houston 3
Livorno 3
Mumbai 3
Ogden 3
Redmond 3
Warsaw 3
Ann Arbor 2
Bengaluru 2
Brno 2
Chicago 2
Fiesole 2
Fuzhou 2
Füllinsdorf 2
Madrid 2
Naples 2
San Diego 2
Toronto 2
Bacoli 1
Belfast 1
Bhubaneswar 1
Cambridge 1
Cogorno 1
Dublin 1
Frascati 1
Kolkata 1
Ljubljana 1
Lucca 1
Monza 1
Norwalk 1
Olomouc 1
Padova 1
Pontotoc 1
Porto Azzurro 1
Shanghai 1
Tacoma 1
Tallinn 1
Tokyo 1
Xiamen 1
Totale 449
Nome #
Longitudinal adherence trajectories to biologic disease modifying anti-rheumatic drugs in Tuscany, Italy 92
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons 91
Validation test for algorithms to identify rheumatoid arthritis patients in the Tuscan healthcare administrative databases 91
Trajectories of use of biologic disease modifying antirheumatic drugs in rheumatoid arthritis: A cohort study of Tuscan patients, Italy 72
Validation of algorithms for selecting rheumatoid arthritis patients in the Tuscan healthcare administrative databases 62
Recommendations by the Tuscan Health Authority to Use Infliximab-Biosimilar in the Clinical Practice: Safety Impact 60
Trajectories of Adherence to Biologic Disease-Modifying Anti-Rheumatic Drugs in Tuscan Administrative Databases: The Pathfinder Study 58
THE ECONOMIC IMPACT OF THE INTRODUCTION OF INFLIXIMAB-BIOSIMILAR: AN EMPIRICAL ANALYSIS USING THE TUSCANY HEALTHCARE ADMINISTRATIVE DATABASES 57
Discontinuation rate to biologic and targeted synthetic DMARDs in rheumatoid arthritis patients: Systematic review and meta-analysis 24
Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy 20
Exploring the relationship between utilization patterns of biologic disease-modifying anti-rheumatic drugs and disease activity in rheumatoid arthritis patients 18
Impact of age and cardiovascular risk factors on the incidence of adverse events in patients with rheumatoid arthritis treated with Janus Kinase inhibitors: data from a real-life multicentric cohort. 14
Totale 659
Categoria #
all - tutte 3.407
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.407


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202133 0 0 0 1 3 0 7 3 5 0 2 12
2021/2022169 6 5 21 36 25 15 9 6 7 4 11 24
2022/2023180 24 38 16 5 13 13 10 2 40 0 19 0
2023/2024152 0 9 14 2 12 26 21 18 1 0 20 29
2024/2025125 7 19 25 42 32 0 0 0 0 0 0 0
Totale 659